Acta Scientific Clinical Case Reports (ASCR)

Editorial Volume 1 Issue 3

Anaphylaxis, its Relevance in the Emergency Department

Eduardo Esteban-Zubero1* and Cristina García-Muro2

1Emergency Department, Hospital San Pedro, Logroño, Spain
2Department of Pediatrics, Hospital San Pedro, Logroño, Spain

*Corresponding Author: Eduardo Esteban-Zubero, Emergency Department, Hospital San Pedro, Logroño, Spain.

Received: February 25, 2020; Published: March 01, 2020


  From a conceptual point of view, anaphylaxis is defined as a systemic disease, potentially serious and fatal, caused by the sudden and massive release of autacoid mediators, cytokines and other pro-inflammatory agents, generated by mast cells and basophils and triggered by immunological causes (usually mediated by IgE-allergen interactions) and non-immunological or unknown causes. Among the best known causes are food (47%), medications, hymenoptera venoms (13%), latex or physical exercise.



  1. Clark S., et al. “ICD-9-CM coding of emergency department visits for food and insect sting allergy”. Annals of Epidemiology 16 (2006): 696-700.
  2. Sampson HA., et al. “Second symposium on the definition and management of anaphylaxis: summary report – second National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network symposium”. Journal of Allergy and Clinical Immunology 117 (2006): 391-397.
  3. Moro Moro M., et al. “Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department”. Journal of Investigational Allergology and Clinical Immunology 21 (2011): 142-149.
  4. Cardona Dahl V and Grupo de trabajo de la Guía GALAXIA de actuación en anafilaxia. “Guideline for the management of anaphylaxis”. Medicina Clinica (Barcelona) 136 (2011): 349-355.
  5. Sheikh A., et al. “Adrenaline for the treatment of anaphylaxis: cochrane systematic review”. Allergy. 64 (2009): 204-212.
  6. Simons FE., et al. “International consensuson (ICON) anaphylaxis”. World Allergy Organization Journal 7 (2014): 9.
  7. Pumphrey R.S. “Lessons for management of anaphylaxis from a study of fatal reactions”. Clinical and Experimental Allergy 30 (2000): 1144-1150.
  8. Mullins R.J. “Anaphylaxis: risk factors for recurrence”. Clinical and Experimental Allergy 33 (2003): 1033-1040.
  9. Pumphrey R.S. “When should self-injectible epinephrine be prescribed for food allergy and when should it be used?” Current Opinion in Allergy and Clinical Immunology 8 (2008): 254-260.
  10. Clark S., et al. “Multicenter study of emergency department visits for food allergies”. Journal of Allergy and Clinical Immunology 113 (2004): 347-353.


Citation: Eduardo Esteban-Zubero and Cristina García-Muro. “Anaphylaxis, its Relevance in the Emergency Department”. Acta Scientific Clinical Case Reports 1.3 (2020): 01-02.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US